Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its... see more

TSXV:SQD.H - Post Discussion

SQI Diagnostics Inc > Antibody testing: full disclosure
View:
Post by 25Stone7859 on Jan 18, 2023 9:04pm

Antibody testing: full disclosure

Antibody testing is not currently recommended to asses immunity after COVID-19 vaccination according to the FDA as of May 19/2021. Nothing has changed in the interim. I understand the CDC and other jurisdictions  have similar filings in place. That is probably why AZOVA cancelled and why SQI could only get approval from the NYSDOH and not the FDA or even Health Canada. The lack of a distribution partner in the US after many months of silence rings loud and clear.  SQI's future rests with RALI-dx; RALI-fast and TOR-dx. These incredible devices will re-charge SQI  and attract investors.
Comment by mercedesman on Jan 19, 2023 11:27am
 While I generally agree with your thesis that momentum has shifted away from Covid Antibody Testing from home, towards Rali-dx etc., I would not discount or completely rule out the future of home testing to ascertain risk factors for Covid and other emerging repiratory viruses (particularily those viruses subject to waniing antibodies over time). The hope was for mass appeal to determine an ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities